Ovarian CancerConnect
Zejula (Niraparib) Improves Progression-Free Survival in Ovarian Cancer
The PARP inhibitor Zejula is a precision cancer medicine that delays ovarian cancer progression and prolongs survival.
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
5 Year follow up data - Lynparza maintenance therapy effective for women with BRCA + and other mutated ovarian cancers.
Ovarian Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Ovarian Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Ovarian Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Ovarian Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Ovarian Cancer Overviews
Overview of Ovarian Cancer
Understand the symptoms, risk factors, diagnosis, tests and the role of screening and early detection of ovarian cancer.
Treatment & Management of Ovarian Cancer
Understand the role of surgery, chemotherapy, and precision cancer medicines in the treatment of Ovarian Cancer.
Maintenance Therapy for Advanced Ovarian Cancer
PARPs and Avastin delay progression when used as maintenance therapy for certain individuals with ovarian cancer.
Treatment of Recurrent Ovarian Cancer
Chemotherapy and maintenance therapy options for recurrent ovarian cancer.
Ovarian Cancer Treatment
Zejula (Niraparib) Improves Progression-Free Survival in Ovarian Cancer
The PARP inhibitor Zejula is a precision cancer medicine that delays ovarian cancer progression and prolongs survival.
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
5 Year follow up data - Lynparza maintenance therapy effective for women with BRCA + and other mutated ovarian cancers.
Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer
PARP inhibitor treatment in ovarian cancer - updated results on risk of MDS and AML
Ovarian Cancer Survivorship
An Aspirin A Day Lowers The Risk of Cancer
What is the evidence that daily aspirin use reduces the risk of developing cancer?
Hereditary Breast and Ovarian Cancer: What you need to know about risk
Ask the Experts Series:
Fertility Preservation for Young Women with Early Ovarian Cancer
Fertility Preservation Appears to Be Safe for Young Women with Early-stage Ovarian Cancer
Gynecologic Oncologists Offer High-Quality Care for Ovarian Cancer
Experience, expertise, and specialization improve outcomes for women with ovarian, endometrial and cervical cancers.